Pharma Lynx, LLC

pharmalynx.com

At Pharma Lynx, we emphasize long-term, value added relationships with a commitment to understand our customer’s business needs. By leveraging proven industry expertise, we concentrate on providing comprehensive Clinical Trials & Data Management Services to the pharmaceutical, biotechnology, generic drug, and medical device companies in the areas of Oncology, Central Nervous System (CNS), Infectious Disease & Vaccines therapeutic areas. Services Offered by Pharma Lynx: - Clinical Development Plan - Site selection - Clinical monitoring - Medical monitoring - Safety monitoring - Data Management/EDC - Biostatistics Analysis - What makes Pharma Lynx unique from other CROs? Data management is a core service of Pharma Lynx and a critical element of our customer value proposition. Pharma Lynx is headquartered out of Princeton, New Jersey, USA with an offshore office in Noida, India, and an exclusive partnership in Munich, Germany.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

PHIO PHARMACEUTICALS ANNOUNCES THREE POSTER PRESENTATIONS AT THE 2020 SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING

Phio Pharmaceuticals Corp | October 26, 2020

news image

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced three upcoming poster presentations discussing INTASYL compounds, including posters being delivered by two development partners, AgonOx, Inc. and the Helmholtz Zentrum München, at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020), to be held virtually...

Read More

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

news image

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More

MOVILITAS.CLOUD™ VRS SOLUTION CLARIFIES DSCSA VERIFICATION FOR PHARMACEUTICAL WHOLESALE DISTRIBUTORS AND MANUFACTURERS

Movilitas | July 13, 2020

news image

Movilitas announced today the availability of its Movilitas.Cloud™ Verification Router Service (VRS) solution that simplifies the verification process and compliance for pharmaceutical wholesale distributors and manufacturers. The new mobile app provides an out-of-the-box solution for the November 2020 Drug Supply Chain Security Act (DSCSA) saleable returns verification deadline. With the upcoming regulation, wholesale distributors must verify the serialized product identifi...

Read More

Business Insights, PHARMA TECH

HOVIONE AND RIPPLE ENTER STRATEGIC PARTNERSHIP TO EXPAND EPIDEL® PLATFORM INTO NON-OPHTHALMIC SPACE

Hovione | March 21, 2023

news image

Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications. The core feature of Ripple's Epidel® technology is the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics without the use of polymers or excip...

Read More
news image

Pharma Tech

PHIO PHARMACEUTICALS ANNOUNCES THREE POSTER PRESENTATIONS AT THE 2020 SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING

Phio Pharmaceuticals Corp | October 26, 2020

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced three upcoming poster presentations discussing INTASYL compounds, including posters being delivered by two development partners, AgonOx, Inc. and the Helmholtz Zentrum München, at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020), to be held virtually...

Read More
news image

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More
news image

MOVILITAS.CLOUD™ VRS SOLUTION CLARIFIES DSCSA VERIFICATION FOR PHARMACEUTICAL WHOLESALE DISTRIBUTORS AND MANUFACTURERS

Movilitas | July 13, 2020

Movilitas announced today the availability of its Movilitas.Cloud™ Verification Router Service (VRS) solution that simplifies the verification process and compliance for pharmaceutical wholesale distributors and manufacturers. The new mobile app provides an out-of-the-box solution for the November 2020 Drug Supply Chain Security Act (DSCSA) saleable returns verification deadline. With the upcoming regulation, wholesale distributors must verify the serialized product identifi...

Read More
news image

Business Insights, PHARMA TECH

HOVIONE AND RIPPLE ENTER STRATEGIC PARTNERSHIP TO EXPAND EPIDEL® PLATFORM INTO NON-OPHTHALMIC SPACE

Hovione | March 21, 2023

Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications. The core feature of Ripple's Epidel® technology is the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics without the use of polymers or excip...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us